Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 540236, 7 pages
http://dx.doi.org/10.1155/2014/540236
Research Article

IDH Mutations: Genotype-Phenotype Correlation and Prognostic Impact

1Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moëlle épinière (CRICM) UMR-S975, 75013 Paris, France
2INSERM U 975, 75013 Paris, France
3CNRS, UMR 7225, 75013 Paris, France
4Institut du Cerveau et de la Moëlle épinière (ICM), Plateforme de Génotypage Séquençage, 75013 Paris, France
5AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratoire de Neuropathologie R. Escourolle, 75013 Paris, France
6AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie 2, 75013 Paris, France
7Fédération de Neurologie Mazarin, Groupe Hospitalier Pitié-Salpêtrière, 75651 Paris Cedex 13, France

Received 14 February 2014; Accepted 7 April 2014; Published 30 April 2014

Academic Editor: Emeline Tabouret

Copyright © 2014 Xiao-Wei Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [19 citations]

The following is the list of published articles that have cited the current article.

  • Pieter Wesseling, Martin van den Bent, and Arie Perry, “Oligodendroglioma: pathology, molecular mechanisms and markers,” Acta Neuropathologica, vol. 129, no. 6, pp. 809–827, 2015. View at Publisher · View at Google Scholar
  • Brian Yard, Eui Kyu Chie, Drew J. Adams, Craig Peacock, and Mohamed E. Abazeed, “Radiotherapy in the Era of Precision Medicine,” Seminars In Radiation Oncology, vol. 25, no. 4, pp. 227–236, 2015. View at Publisher · View at Google Scholar
  • Liang Xia, Bin Wu, Fang Feng, Qinglin Li, Caixing Sun, Zhiquan Fu, Enqi Qiao, and Minghua Ge, “Prognostic role of IDH mutations in gliomas: A meta-analysis of 55 observational studies,” Oncotarget, vol. 6, no. 19, pp. 17354–17365, 2015. View at Publisher · View at Google Scholar
  • Ning Liu, Hong-Wang Song, Kun Yao, Peng-Fei Wang, Tao Jiang, Shou-Wei Li, and Chang-Xiang Yan, “IDH-1R132H mutation status in diffuse glioma patients: Implications for classification,” Oncotarget, vol. 7, no. 21, pp. 31393–31400, 2016. View at Publisher · View at Google Scholar
  • Hendrikus J. Dubbink, Peggy N. Atmodimedjo, Johan M. Kros, Pim J. French, Marc Sanson, Ahmed Idbaih, Pieter Wesseling, Roelien Enting, Wim Spliet, Cees Tijssen, Winand N. M. Dinjens, Thierry Gorlia, and Martin J. van den Bent, “Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Gr,” Neuro-Oncology, vol. 18, no. 3, pp. 388–400, 2016. View at Publisher · View at Google Scholar
  • Charles Marc Leyrer, Erin Murphy, and Manmeet Ahluwaliapp. 251–263, 2016. View at Publisher · View at Google Scholar
  • P. Hillmann, D. Schmitz, J. Mestan, S. D'Alonzo, and D. Fabbro, “Cancer Biology and the Principles of Targeted Cancer Drug Discovery,” Reference Module in Chemistry, Molecular Sciences and Chemical Engineering, 2016. View at Publisher · View at Google Scholar
  • Jacolien E.C. Bromberg, Martin J. Van Den Bent, and Jan Buckner, “Low-grade and anaplastic oligodendroglioma,” Handbook of Clinical Neurology, vol. 134, pp. 361–380, 2016. View at Publisher · View at Google Scholar
  • N. V. Lobanova, L. V. Shishkina, M. V. Ryzhova, G. L. Kobyakov, R. V. Sycheva, S. A. Burov, A. V. Lukyanov, and Zh. R. Omarova, “Clinical, immunohistochemical, and molecular genetic prognostic factors in adult patients with glioblastoma,” Arkhiv patologii, vol. 78, no. 4, pp. 10, 2016. View at Publisher · View at Google Scholar
  • S. V. Saakyan, I. P. Khoroshilova-maslova, А. Yu. Tsygankov, А. G. Amiryan, and R. Т. Isaeva, “Pathological and molecular genetic characteristics in patients with extrabulbar growth of uveal melanoma,” Arkhiv patologii, vol. 78, no. 4, pp. 20, 2016. View at Publisher · View at Google Scholar
  • Hongyang Lu, Haimiao Xu, Na Han, Weimin Mao, Jing Qin, and Fajun Xie, “O6-methyl-guanine-DNA methyltransferase methylation and IDH1/2 mutation in small cell lung cancer,” Experimental and Therapeutic Medicine, vol. 14, no. 1, pp. 398–402, 2017. View at Publisher · View at Google Scholar
  • Martin J. Van Den Bent, Michael Weller, Patrick Y. Wen, Johan M. Kros, Ken Aldape, and Susan Chang, “A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics,” Neuro-Oncology, vol. 19, no. 5, pp. 614–624, 2017. View at Publisher · View at Google Scholar
  • Michela Visani, Alba A Brandes, Dario de Biase, Giorgia Acquaviva, Gianluca Marucci, Alexandro Paccapelo, Antonella Mura, Enrico Franceschi, Daniela Grifoni, Annalisa Pession, and Giovanni Tallini, “Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria.,” Journal of neuro-oncology, vol. 135, no. 2, pp. 245–254, 2017. View at Publisher · View at Google Scholar
  • Marta Lopes, Bruno Carvalho, Rui Vaz, and Paulo Linhares, “Influence of neutrophil–lymphocyte ratio in prognosis of glioblastoma multiforme,” Journal of Neuro-Oncology, 2017. View at Publisher · View at Google Scholar
  • Torstein R. Meling, Anna Latysheva, Kyrre Eeg Emblem, Andrés Server, Petter Brandal, Jens Pahnke, and John K. Hald, “Survival Associations Using Perfusion and Diffusion Magnetic Resonance Imaging in Patients with Histologic and Genetic Defined Diffuse Glioma World Health Organization Grades II and III,” Journal of Computer Assisted Tomography, vol. 42, no. 5, pp. 807–815, 2018. View at Publisher · View at Google Scholar
  • Bingbing Wang, Jixin Shou, Jiachao Lu, and Longlong Li, “Prognostic value of isocitrate dehydrogenase gene mutation in patients with gliomas: A Meta-analysis,” Tumor, vol. 38, no. 9, pp. 866–873, 2018. View at Publisher · View at Google Scholar
  • Ferenc Kálovits, Bernadette Kálmán, Márton Tompa, and Ádám Nagy, “Isocitrate dehydrogenase mutations in defining the biology of and supporting clinical decision making in glioblastoma,” Ideggyogyaszati Szemle, vol. 71, no. 7-8, pp. 237–247, 2018. View at Publisher · View at Google Scholar
  • Liping Xu, Changyu Sun, and Zhihao Zhang, “Comprehensive characterization of cancer genes in hepatocellular carcinoma genomes,” Oncology Letters, vol. 15, no. 2, pp. 1503–1510, 2018. View at Publisher · View at Google Scholar
  • Caroline Bund, Mariana Guergova-Kuras, A. Ercument Cicek, François-Marie Moussallieh, Nassim Dali-Youcef, Martial Piotto, Pilar Schneider, Rémy Heller, Natacha Entz-Werle, Benoît Lhermitte, Marie-Pierre Chenard, Roland Schott, François Proust, Georges Noël, and Izzie Jacques Namer, “An integrated genomic and metabolomic approach for defining survival time in adult oligodendrogliomas patients,” Metabolomics, vol. 15, no. 5, 2019. View at Publisher · View at Google Scholar